Favrille, Inc (FVRL)

Company Overview
Favrille, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies for the treatment of cancer and other diseases of the immune system. It offers FavId, which is in Phase III clinical trials, for the treatment of B-cell non-Hodgkin’s lymphoma. The company’s technology enables in manufacturing immunotherapy products that are designed to stimulate a patient’s immune system to mount a specific and sustained response to diseases. It also develops FAV-201 for the treatment of T-cell lymphoma. In addition, the company intends to initiate preclinical studies to identify additional product candidates for the treatment of autoimmun...
read more

QUOTE

As of 11:21PM EDT July 30, 2014
$ N/A   N/A (N/A%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: N/A
52 Week High: N/A Bid (size): N/A
52 Week Low: N/A Ask (size): N/A

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: -
Mailing Address: 4401 WILSHIRE BLVD. SUITE 200 LOS ANGELES CA 90010 Business Address 4401 WILSHIRE BLVD. SUITE 200 LOS ANGELES CA 90010 310 476 7002
Phone: 858-526-8000
Fax: 858-597-7040
Website: http://www.favrille.com

Company Details:

Symbol: FVRL
SIC: 1285701
State location: CA
Sector: -
State of Inc: DE
Employees: 12
Type: NASDAQ

Key executives:

Name Age Position

LATEST ARTICLES

LATEST STOCK PROMOTIONS

Favrille, Inc (FVRL) MESSAGE BOARD

Post # Subject Re Name Date
1 This message board is to discuss Favrille,... 0
2 Here on this message board we are inviting... 0